Upexi Inc. (UPXI)
NASDAQ: UPXIFinanceFinance: Consumer ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
UPXI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $41.07M
- EPS (TTM)
- -$4.14
- Dividend yield
- None
- 52-week range
- 0.4205 – 3.03
- Day range
- 0.4205 – 0.54
- Volume / Avg
- 2.14M / 3.02M
- Beta
- —
- Shares outstanding
- 88.86M
52-week range
UPXI stock today
On Nov 20, UPXI ended the session at $0.4622, shedding $0.0861 (15.70%), versus the S&P 500's 3.70% decline. At this level, UPXI sits near the bottom of its 52-week range of $0.4205 to $3.03: 84.7% below the high, set on Nov 25, 2025 and 9.9% above the low. UPXI is down 72.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 81.7%.
Upexi has posted a net loss over the last twelve months (EPS of -$4.14), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Upexi
Company profileUpexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; and functional mushrooms under the Cure Mushrooms brand.
Financial highlights
Full financialsIn fiscal 2026, Upexi generated $25.0 million in revenue, up 58.1% from fiscal 2025. Upexi reported a net loss of $246.1 million, compared with a loss of $13.7 million a year earlier. Gross margin was 89.5% (up from 68.7%) and operating margin -963.5%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $25.00M | $15.81M | $26.00M | $36.44M | $23.07M |
| Growth | +58.10% | -39.19% | -28.65% | +57.99% | -4.27% |
| Net income | $-246.06M | $-13.68M | $-23.66M | $-17.49M | $-2.05M |
| EPS (diluted) | $-3.87 | $-1.73 | $-23.03 | $-18.94 | $-0.43 |
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$2.00+332.71%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $0.68 vs —
UPXI news
All UPXI newsUpexi peers
Finance sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NCTYThe9 Limited American Depository Shares | 2.60 | -10.96% | $39.71M | vs UPXI |
| CNFCNFinance Holdings Limited ADR | 2.33 | +12.56% | $39.28M | vs UPXI |
| GRANGrande Group Limited Class A | 1.34 | +4.28% | $42.86M | vs UPXI |
| MATHMetalpha Technology Holding Limited | 0.7611 | -13.21% | $36.18M | vs UPXI |
| AUREAurelion Inc. Class A | 1.01 | -1.47% | $34.84M | vs UPXI |
| BTCSBTCS Inc. | 0.653 | -12.23% | $34.58M | vs UPXI |
| HYPDHyperion DeFi Inc. | 2.08 | -11.11% | $31.72M | vs UPXI |
| SUIGSui Group Holdings Limited | 0.6591 | -11.05% | $50.62M | vs UPXI |
Indexes, lists and sector
Upexi stock FAQ
What is Upexi's stock price today?
UPXI last traded at $0.4622 as of Nov 20, 4:00 PM EST, down 15.70% on the day. Prices are delayed at least 15 minutes.
Does Upexi pay a dividend?
No. Upexi does not currently pay a regular cash dividend.
Who is Upexi's CEO?
Mr. Allan J. Marshall is the chief executive officer of Upexi Inc., which has about 10 employees.
Has UPXI ever split its stock?
Yes. The most recent UPXI stock split was a 1-for-20 split on Oct 3, 2024.
What is the UPXI 52-week high?
The 52-week high for UPXI is $3.03 and the 52-week low is $0.4205. The stock is currently 84.7% below its high.